캐뉼라 시장 보고서 : 제품별, 유형별, 사이즈별, 소재별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global cannula market size reached USD 168.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 278.8 Million by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The market is driven by the growing need for life-saving techniques like fluid resuscitation and quick medicine delivery to treat heart strokes, rising demand for long-term care institutions and home healthcare services, and thriving medical tourism industry.

Cannula Market Trends:

Increasing prevalence of cardiovascular diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, around 17.9 million people died annually due to cardiovascular diseases. A number of procedural uses for cannulas include aspiration, fluid administration, and the insertion of various medical devices in procedures, such as coronary artery bypass grafting (CABG), angioplasty, and stent placements, which are necessary to treat cardiovascular illnesses. Procedures like cardiac catheterization, which are used to diagnose cardiovascular illness, require cannulas. The prevalence of CVDs is rising, which is driving up the demand for these diagnostic methods. Heart attacks and strokes are common in patients with cardiovascular disorders, necessitating emergency medical attention. When it comes to life-saving techniques like fluid resuscitation and quick medicine delivery, cannulas are indispensable in emergency care.

Aging population

The prevalence of chronic illnesses and other health issues needing medical attention usually increases with age. In order to monitor and treat a variety of illnesses, cannulas are necessary for intravenous therapies, diagnostic procedures, and surgical procedures. Chronic disorders like diabetes, respiratory conditions, and cardiovascular problems are increasingly common in the elderly. The cannula demand is increasing dramatically due to their widespread use in the management and treatment of various illnesses. Osteoarthritis and cataracts are two disorders that often require surgery to address. Cannulas are commonly utilized to provide surgical access, deliver fluids, and distribute drugs during various procedures. As people age, there is an increasing need for home healthcare services and long-term care facilities. Elderly patients' needs can be met outside of hospitals by the use of cannulas in home settings for intravenous therapy and other medical procedures. As per an article by the World Health Organization (WHO), the number of people aged 60 years and above are expected to reach 1.4 billion by 2030 and 2.1 billion by 2050.

Thriving medical tourism industry

The IMARC Group's report shows that the global medical tourism market size reached US$ 119.7 Billion in 2023. Traveling overseas for medical treatment, such as surgeries and therapies, that frequently necessitate the use of cannulas, is known as medical tourism. Popular medical tourism sites see an increase in demand for medical devices, such as cannulas, due to the influx of patients. Many nations make investments in developing their healthcare infrastructure and facilities to accommodate medical tourists. This involves supplying cutting-edge medical equipment, such as cannulas, to clinics and hospitals and comply with global regulations and draw in more patients. Medical tourists often seek for lower cost medical care as compared to their own countries. Cannulas are utilized in a variety of surgical and therapeutic treatments, which helps these locations provide healthcare services at a lower cost and attracts more foreign patients.

Cannula Market Segmentation:

Breakup by Product:

• Cardiac Cannulas
• Nasal Cannulas
• Vascular Cannulas
• Dermatology Cannulas
• Arthroscopy Cannulas
• Others

Cardiac cannulas account for the majority of the market share

Because they are essential for heart surgeries and treatments, cardiac cannulas are the most common product category in the market. Specialty cannulas such as these are designed specifically to access and manipulate the heart during cardiac surgeries, coronary artery bypass grafting (CABG), and valve replacements. They aid in ensuring that medications, fluids, and anesthesia are accurately administered to the heart during surgeries and enable effective drainage and irrigation. The need for cardiac cannulas is increasing dramatically due to the rising incidence of cardiovascular disorders around the world and improvements in surgical methods that favor less invasive procedures.

Breakup by Type:

• Neonatal Cannulas
• Straight Cannulas
• Winged Cannula
• Wing with Port Cannula
• Others

Straight cannulas hold the largest share of the industry

The market for cannulas has seen a rise in the number of straight cannulas, mostly because of their broad range of medical procedure applications. The simple form of these cannulas makes it possible to implant them easily and transport gases, liquids, and prescriptions into the body precisely. They are frequently utilized in diagnostic procedures, blood transfusions, and intravenous (IV) therapy, where simple access and fluid delivery are critical. Because they can be quickly deployed and consistently give essential care, straight cannulas are the preferable option in emergency situations. Additionally, because of their accessibility, affordability, and simplicity, healthcare facilities around the world find them intriguing.

Breakup by Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G

18G represents the leading market segment

18G (Gauge) cannulas are the most popular size category in the market due to their extensive and adaptable use in medical operations. These 18G diameter cannulas are ideal for a range of applications because they balance fluid flow rate and patient comfort. They are frequently used in blood transfusions, where effective flow is crucial, and intravenous (IV) therapy for the administration of drugs and fluids. The 18G size is also preferred in emergency medicine since it can administer medications fast in life-threatening circumstances.

Breakup by Material:

• Plastic (PVC) Cannulas
• Silicone Cannulas
• Metal Cannulas (Stainless Steel)

Plastic (PVC) cannulas exhibit a clear dominance in the market

Because of their broad use and numerous healthcare applications, plastic (PVC) cannulas are becoming the most popular material type in the cannula industry. PVC cannulas are preferred because they are adaptable, reasonably priced, and suitable for a variety of medical operations. As they can maintain sterile conditions and guarantee patient comfort, they are frequently employed in intravenous (IV) therapy for the administration of fluids and medicine delivery. PVC cannulas are also widely used in blood collection because of their flat surface, which makes sample collection and blood flow more efficient, thereby contributing to the cannula market size. They are appropriate for both long-term use in chronic care settings and short-term therapies due to their lightweight and sturdy design.

Breakup by Application:

• Cardiovascular Surgery
• Oxygen Therapy
• General Surgery
• Cosmetic/Plastic Surgery
• Orthopedic Surgery
• Others

Because cardiovascular disorders are becoming more commonplace worldwide, there is a substantial need for cannulas in the cardiovascular surgery industry. The cardiac cannulas used in CABG and valve replacement surgeries, among other surgeries, are essential for accessing and repositioning the heart throughout the procedure. These customized cannulas allow for efficient drainage and irrigation as well as accurate administration of drugs, fluids, and anesthetic to the heart.

Oxygen therapy cannulas represent a significant portion of the market. These cannulas, usually nasal cannulas, are vital for providing patients with respiratory disorders with extra oxygen or for use during surgical procedures, which is positively influencing the cannula market value. For patients in need of both short-term and long-term oxygen therapy, they offer a convenient and effective way to administer oxygen. The need for oxygen therapy cannulas is still high due to the rise in respiratory illnesses and oxygenation-related ailments, as well as the development in technology that improve patient comfort and treatment effectiveness.

Within the field of general surgery, cannulas are utilized for a variety of functions, such as IV treatment, during different surgical procedures. Cannulas are used in general surgery to allow precise access for therapeutic and diagnostic treatments, as well as to assist the introduction of fluids, medicines, and anesthetics. Their dependability and adaptability make them essential for both elective and emergency surgeries, which contributes to their consistent demand in medical facilities across the globe.

Breakup by End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others

Hospitals are the predominant market segment

Due to their critical position as primary healthcare providers and locations for medical procedures, hospitals stand out as the largest end-user category in the market. Intensive care units (ICUs), regular patient wards, surgery, and emergency departments are just a few of the areas in hospitals where cannulas are essential to daily operations. They enable the accurate and effective delivery of fluids and drugs to patients during intravenous (IV) therapy, medication administration, blood transfusions, and surgical procedures. The strong demand for cannulas is maintained by the sheer volume of medical treatments carried out in hospitals as well as the rising prevalence of surgical procedures and chronic disorders.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest cannula market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for cannula.

Because of its sophisticated healthcare system, rising healthcare costs, and high prevalence of chronic illnesses requiring medical interventions, North America leads the world in cannula sales. Extensive research and development (R&D) efforts supporting the region's dominance are resulting in ongoing advancements in medical equipment, including cannulas. The need for cannulas in a variety of medical specialties, including cardiology, oncology, and emergency medicine, is fueled by the fact that North American healthcare facilities, especially those in the United States and Canada, place a high priority on patient safety, efficiency, and quality of service. Adoption of new medical technologies, such as cannulas, in clinical practice is further supported by advantageous reimbursement policies and strong healthcare laws, thereby propelling the cannula market growth. There is an increasing need for cannula-based surgical operations and medical therapies as the aging population and the prevalence of chronic diseases are rising. Moreover, key players operating the region are focusing on getting patent approvals for their products. For instance, in 2023, Inspira(TM) Technologies OXY B.H.N. Ltd. announced that the novel convertible dual lumen cannula device and method of use, being developed for the INSPIRA(TM) ART System, has been granted a patent by the U.S. Patent and Trademark Office (USPTO).

Competitive Landscape:

• The cannula market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the cannula industry include Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

• Major firms in the industry are actively taking part in a number of strategic projects aimed at bolstering their market shares and promoting expansion. In order to innovate and improve cannula designs and increase patient comfort, safety, and efficacy, these companies are making significant investments in research and development (R&D) activities. To meet the needs of developing healthcare markets and a variety of medical applications, they are also diversifying their product lines. Cannula companies frequently engage in strategic alliances, mergers, and acquisitions to expand their technological prowess and consumer base. For instance, in 2024, BD (Becton, Dickinson and Company) announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash. Top companies are also concentrating on geographical growth into developing countries to take advantage of the rising demand for cutting-edge medical products in these areas. To boost knowledge and uptake of their goods, marketing campaigns and educational initiatives targeted at healthcare professionals are also given top priority, which is increasing the cannula market revenue.

Key Questions Answered in This Report

• 1.What was the size of the global cannula market in 2024?
• 2.What is the expected growth rate of the global cannula market during 2025-2033?
• 3.What are the key factors driving the global cannula market?
• 4.What has been the impact of COVID-19 on the global cannula market?
• 5.What is the breakup of the global cannula market based on the product?
• 6.What is the breakup of the global cannula market based on the type?
• 7.What is the breakup of the global cannula market based on size?
• 8.What is the breakup of the global cannula market based on the material?
• 9.What is the breakup of the global cannula market based on the end user?
• 10.What are the key regions in the global cannula market?
• 11.Who are the key players/companies in the global cannula market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cannula Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Cardiac Cannulas
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Nasal Cannulas
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Vascular Cannulas
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Dermatology Cannulas
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Arthroscopy Cannulas
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Type

• 7.1 Neonatal Cannulas
  • 7.1.1 Market Trends
  • 7.1.3 Market Forecast
• 7.2 Straight Cannulas
  • 7.2.1 Market Trends
  • 7.2.3 Market Forecast
• 7.3 Winged Cannula
  • 7.3.1 Market Trends
  • 7.3.3 Market Forecast
• 7.4 Wing with Port Cannula
  • 7.4.1 Market Trends
  • 7.4.3 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.3 Market Forecast

8 Market Breakup by Size

• 8.1 14G
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 16G
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 18G
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 20G
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 22G
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 24G
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast
• 8.7 26G
  • 8.7.1 Market Trends
  • 8.7.2 Market Forecast

9 Market Breakup by Material

• 9.1 Plastic (PVC) Cannulas
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Silicone Cannulas
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Metal Cannulas (Stainless Steel)
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Application

• 10.1 Cardiovascular Surgery
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Oxygen Therapy
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 General Surgery
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Cosmetic/Plastic Surgery
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Orthopedic Surgery
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast
• 10.6 Others
  • 10.6.1 Market Trends
  • 10.6.2 Market Forecast

11 Market Breakup by End-User

• 11.1 Hospitals
  • 11.1.1 Market Trends
  • 11.1.2 Market Forecast
• 11.2 Ambulatory Surgery Centers (ASCs)
  • 11.2.1 Market Trends
  • 11.2.2 Market Forecast
• 11.3 Others
  • 11.3.1 Market Trends
  • 11.3.2 Market Forecast

12 Market Breakup by Region

• 12.1 North America
  • 12.1.1 United States
    • 12.1.1.1 Market Trends
    • 12.1.1.2 Market Forecast
  • 12.1.2 Canada
    • 12.1.2.1 Market Trends
    • 12.1.2.2 Market Forecast
• 12.2 Asia Pacific
  • 12.2.1 China
    • 12.2.1.1 Market Trends
    • 12.2.1.2 Market Forecast
  • 12.2.2 Japan
    • 12.2.2.1 Market Trends
    • 12.2.2.2 Market Forecast
  • 12.2.3 India
    • 12.2.3.1 Market Trends
    • 12.2.3.2 Market Forecast
  • 12.2.4 South Korea
    • 12.2.4.1 Market Trends
    • 12.2.4.2 Market Forecast
  • 12.2.5 Australia
    • 12.2.5.1 Market Trends
    • 12.2.5.2 Market Forecast
  • 12.2.6 Indonesia
    • 12.2.6.1 Market Trends
    • 12.2.6.2 Market Forecast
  • 12.2.7 Others
    • 12.2.7.1 Market Trends
    • 12.2.7.2 Market Forecast
• 12.3 Europe
  • 12.3.1 Germany
    • 12.3.1.1 Market Trends
    • 12.3.1.2 Market Forecast
  • 12.3.2 France
    • 12.3.2.1 Market Trends
    • 12.3.2.2 Market Forecast
  • 12.3.3 United Kingdom
    • 12.3.3.1 Market Trends
    • 12.3.3.2 Market Forecast
  • 12.3.4 Italy
    • 12.3.4.1 Market Trends
    • 12.3.4.2 Market Forecast
  • 12.3.5 Spain
    • 12.3.5.1 Market Trends
    • 12.3.5.2 Market Forecast
  • 12.3.6 Russia
    • 12.3.6.1 Market Trends
    • 12.3.6.2 Market Forecast
  • 12.3.7 Others
    • 12.3.7.1 Market Trends
    • 12.3.7.2 Market Forecast
• 12.4 Latin America
  • 12.4.1 Brazil
    • 12.4.1.1 Market Trends
    • 12.4.1.2 Market Forecast
  • 12.4.2 Mexico
    • 12.4.2.1 Market Trends
    • 12.4.2.2 Market Forecast
  • 12.4.3 Others
    • 12.4.3.1 Market Trends
    • 12.4.3.2 Market Forecast
• 12.5 Middle East and Africa
  • 12.5.1 Market Trends
  • 12.5.2 Market Breakup by Country
  • 12.5.3 Market Forecast

13 SWOT Analysis

• 13.1 Overview
• 13.2 Strengths
• 13.3 Weaknesses
• 13.4 Opportunities
• 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

• 15.1 Overview
• 15.2 Bargaining Power of Buyers
• 15.3 Bargaining Power of Suppliers
• 15.4 Degree of Competition
• 15.5 Threat of New Entrants
• 15.6 Threat of Substitutes

16 Price Indicators

17 Competitive Landscape

• 17.1 Market Structure
• 17.2 Key Players
• 17.3 Profiles of Key Players
  • 17.3.1 Boston Scientific Corporation
    • 17.3.1.1 Company Overview
    • 17.3.1.2 Product Portfolio
    • 17.3.1.3 Financials
    • 17.3.1.4 SWOT Analysis
  • 17.3.2 CONMED Corporation
    • 17.3.2.1 Company Overview
    • 17.3.2.2 Product Portfolio
    • 17.3.2.3 Financials
    • 17.3.2.4 SWOT Analysis
  • 17.3.3 Edwards Lifesciences
    • 17.3.3.1 Company Overview
    • 17.3.3.2 Product Portfolio
    • 17.3.3.3 Financials
    • 17.3.3.4 SWOT Analysis
  • 17.3.4 Medtronic Plc
    • 17.3.4.1 Company Overview
    • 17.3.4.2 Product Portfolio
    • 17.3.4.3 Financials
    • 17.3.4.4 SWOT Analysis
  • 17.3.5 Smith & Nephew PLC
    • 17.3.5.1 Company Overview
    • 17.3.5.2 Product Portfolio
    • 17.3.5.3 Financials
    • 17.3.5.4 SWOT Analysis
  • 17.3.6 Smiths Medical Inc.
    • 17.3.6.1 Company Overview
    • 17.3.6.2 Product Portfolio
    • 17.3.6.3 SWOT Analysis
  • 17.3.7 LivaNova Plc
    • 17.3.7.1 Company Overview
    • 17.3.7.2 Product Portfolio
  • 17.3.8 Teleflex Incorporated
    • 17.3.8.1 Company Overview
    • 17.3.8.2 Product Portfolio
    • 17.3.8.3 Financials
    • 17.3.8.4 SWOT Analysis
  • 17.3.9 Terumo Corporation
    • 17.3.9.1 Company Overview
    • 17.3.9.2 Product Portfolio
    • 17.3.9.3 Financials
    • 17.3.9.4 SWOT Analysis